Cytosorbents Corp (CTSO) KPIs and segments
Close on Nov 12, 2026Market cap $337.47MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Cytosorbents's business
Cytosorbents's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All other countries($M) | 6.89 | 6.13 | 6.20 | 5.87 | |||||||||
Germany($M) | 2.54 | 2.61 | 3.36 | 2.80 | |||||||||
United States($M) | 0.20 | 0.12 | 0.06 | 0.06 | |||||||||
Earlier reporting (last reported 2024)3 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?